Latest Breaking News On - Hitachi medical corporation - Page 7 : vimarsana.com

United States Breast Cancer Screening Market Size Is Booming Worldwide With | Hitachi Medical Corporation, GE Healthcare | Taiwan News

United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022. Long–term Growth Projection: • Mammography grasp the dominant share in the United States Breast Cancer Screening Market • Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022 • Number of mammograpy screening population […] | 2023-05-08 12:20:16

United statesSiemen healthineersMajor companies covered in thisToshiba medical systems corporationCompany countryHitachi medical corporationGe healthcareUnited states breast cancer screening marketGrowth projectionUnited states breast cancer screeningFree sampleStates breast cancer screening market analysisClinical trials insightCompetitive strategiesPhilips healthcareTopics covered

Precision Cancer Imaging Market is anticipated to reach a valuation of US$ 210 58 Billion by 2032, at a CAGR of 12% | Future Market Insights, Inc

Precision Cancer Imaging Market is anticipated to reach a valuation of US$ 210 58 Billion by 2032, at a CAGR of 12% | Future Market Insights, Inc
fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkSouth africaFujifilm holdings corporation japanShimadzu corporation japanToshiba corporation japanHologic incHitachi ltdCarestream healthGreater new york chamberNuclear imagingHitachi medical corporation japanMarket insights incPrecision cancer imaging marketPrecision cancer imagingLatest market insights

Global Radiography Systems Market Report 2022: Increasing Use of Ai-Enabled Diagnostic Equipment for Rapid Diagnosis and Predictive Analysis Bolsters Growth

/PRNewswire/ The "Global Radiography Systems Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Type, Application, End User and Regions".

United statesUnited kingdomSouth koreaLaura woodAsia pacificKoninklijke philipsAnalysis of the global radiography systems industryOverview of notable emerging competitor companiesAnalogic corporationCarestream healthNuclear imaging equipmentHitachi medical corporationDiagnostics ltdShimadzu corporationSamsung medison coOffice hours call

Brain Tumor Drugs Global Market Report 2023: A $4 74

Dublin, March 24, 2023 (GLOBE NEWSWIRE) The "Brain Tumor Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's.

United statesUnited kingdomSouth koreaBristol myers squibbSiemens healthineersAfinitor disperz everolimusAstellas pharmaAfinitor everolimusDrug administrationCelgene corporationCarestream healthGe healthcareEuropean medicines agencyShimadzu corporationMacleods pharmaceuticalPfizer inc

Prostate Cancer Radiotherapy Market to Register a Steady CAGR of 5 30% Between 2023 – 2031 – Growth Plus Reports |

The global prostate cancer radiotherapy market is projected to register a revenue CAGR of 5.30% between 2023 to 2031, according to the latest evaluation

United statesAsia pacificManan sethiCustomer base assessmentA free sample copy of the researchEphmra european pharmaceutical marketing research associationContract research organizationGe healthcare technologies incRadiomedix incOsaka universityContract developmentStrategic developmentManufacturing organizationFusion pharmaceuticalsTechnology internal neuromodulationHitachi medical corporation